Dr. Otmane

Dr. Otmane Boussif

Chief Technology Officer CMC Biologics - Cell & Gene Therapies
Anjarium Biosciences

Dr. Otmane Boussif, currently serving as the Chief Technical Officer at Anjarium Biosciences AG, a
company developing a new cell-free synthetic DNA platform for Cell & Gene Therapy (CGT)
modalities production. With over 25 years of experience, Dr. Boussif has played pivotal roles in
various leading companies.
At Novartis, he held several significant positions, including Global Head of Cell and Gene Therapy
Technical Development and Global Head of Early Phase Development. His expertise spans biologics,
CGT process development, characterization, and validation. Dr. Boussif’s leadership has been
instrumental in successfully advancing projects from preclinical stages to commercialization and life
cycle management (LCM).

Pieere Wills n

Pierre Wills

Global Scientific Advisory Lead - mRNA Center of Excellence

Pierre graduated from the Institut National Agronomique in Paris, France and received his PhD in Molecular
and Cellular Pharmacology at the Institut Gustave Roussy. He has over 30 year experience in the pharmaceutical
industry, and held positions in preformulation and formulation development for both small molecules and
biotherapeutics, including gene delivery technologies. He was involved in the CMC development and
contributed to the successful filing and approval of several drugs, such as Jevtana, Kevzara or Sarclisa.

Jeane n

Jeane René Authelin

Senior Scientific Advisor, global CMC,

Jean René Authelin has an Engineer degree in chemical Engineering from ENSIC (Nancy
France), and a PhD from The Institut National Polytechnique de Lorraine (France). He joined
Rhone Poulenc in 1988 as a Chemical Engineer. In the 90’s he founded the Physical Quality
function, dedicated to the API crystallization, drying, polymorphism, particle engineering…
for which he was for 10 years Global Head in Rhone Poulenc Rorer, Aventis and finally
sanofi . In, 2008 JR Authelin was nominated Global Head of Pharmaceutical Engineering.
Since 2020 JR Authelin is Senior Scientific Advisor, global CMC, reporting to the global
CMC head.


Mostafa Nakach

Global head of process engineering for biologic drug product development

Mostafa Nakach is PhD from Toulouse University.  He has prepared his thesis on stabilization and production of
nanocrystalline suspension. He is also Master 2 graduate from Paris-sud 11 university in Pharmacotechnie and
Biopharmacy and Pharmaceutical engineer from Ecole des Mines d’Albi. Mostafa has been working within the
Sanofi group for 34 years. Currently, Mostafa is working within biologic drug product development as head of
formulation & process development. His mission is to build and to manage the required skills and capabilities in
order to support R&D projects development mainly for Fill & finish lab & commercial process development of
biotech products including freeze drying.


Challenges and Opportunities Icon-01

Challenges and Opportunities in Developing Complex injectables

Regulatory Landscape Icon-01

Regulatory Landscape and  Guidance of Complex Injectables

Lifecycle Management Icon-01

Lifecycle Management of Combination product Development

Primary Packaging Icon-01

Primary Packaging and CMC considerations for Injectables

Technology Transfer Challenges Icon-01

Scale-up and technology Transfer Challenges  of Injectables

Digital Technologies Icon-01

Digital Technologies to design Novel Drug-Device Combination products.

Challenges and Opportunities Icon-01

Latest technologies for next generation device design


  • As a speaker play an active role in shaping industry leading-event
  • Be Internationally recognized as industry thought leader
  • Network with cross-industry peers across the industry
  • Have your profile features in the conference website, brochure and marketing campaigns. 
  • Have your expertise highlighted via webinars, thought leader articles or exclusive interviews issued on our magazine and online portal. 
  • Gain a discounted/complimentary pass (inclusive of access to all sessions, seated meals, networking drinks, a certification, and a PDF copy of all presentations [post-event) to the conference and additional discounted pass to share with colleagues.

Keep in mind the following guidelines when considering what to submit:

  • Speaking submissions don’t need to be finalized presentations; it’s fine if they are just an idea. We can work with you on filling in the gaps.
  • You can submit more than one proposal — fill out the form as many times as you need.
  • Solo, dual, and panel presentations are all welcome.
  • Presentations should be about 30-40 minutes long.
  • Please, no sales pitches!

Submit The Form For Your Speaking Proposal